Oligomerization of optineurin and its oxidative stressor E50k mutation-driven covalent cross-linking: Possible relationship with glaucoma pathology

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Gao, Jie ^a   Ohtsubo, Masafumi ^a   Hotta, Yoshihiro ^a   Minoshima, Shinsei ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DODECYL SULFATE SODIUM; OPTINEURIN; UBIQUITIN; OPTN PROTEIN, HUMAN; TRANSCRIPTION FACTOR IIIA;

3T3 CELL LINE; ARTICLE; BLUE NATIVE GEL ELECTROPHORESIS; CELL ASSAY; CONTROLLED STUDY; COVALENT BOND; ENVIRONMENTAL FACTOR; GEL ELECTROPHORESIS; GENE MUTATION; GLAUCOMA; IMMUNOPRECIPITATION; MOLECULAR WEIGHT; MUTATIONAL ANALYSIS; OLIGOMERIZATION; OPTN GENE; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN CROSS LINKING; PROTEIN LOCALIZATION; PROXIMITY LIGATION ASSAY; ANIMAL; GENETICS; HELA CELL LINE; HUMAN; METABOLISM; MOUSE; MUTATION; POLYMERIZATION;

ANIMALS; HELA CELLS; HUMANS; MICE; MUTATION; NIH 3T3 CELLS; OXIDATIVE STRESS; POLYMERIZATION; TRANSCRIPTION FACTOR TFIIIA; UBIQUITIN;

EID: 84903748240     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101206     Document Type: Article

References (58)

1. Rezaie T, Child A, Hitchings R, Brice G, Miller L, et al. (2002) Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295: 1077-1079. (Pubitemid 34132238)
2. Quigley HA (1996) Number of people with glaucoma worldwide. Br J Ophthalmol 80: 389-393.
3. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY (1995) Global data on blindness. Bull World Health Organ 73: 115-121.
4. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, et al. (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82: 844-851. (Pubitemid 39573742)
5. Tezel G (2006) Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res 25: 490-513.
6. Nakazawa T, Nakazawa C, Matsubara A, Noda K, Hisatomi T, et al. (2006) Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci 26: 12633-12641. (Pubitemid 44904557)
7. Hauser MA, Sena DF, Flor J, Walter J, Auguste J, et al. (2006) Distribution of optineurin sequence variations in an ethnically diverse population of low-tension glaucoma patients from the United States. J Glaucoma 15: 358-363. (Pubitemid 44434987)
8. Aung T, Rezaie T, Okada K, Viswanathan AC, Child AH, et al. (2005) Clinical features and course of patients with glaucoma with the E50K mutation in the optineurin gene. Invest Ophthalmol Vis Sci 46: 2816-2822. (Pubitemid 43086703)
9. Ying H, Yue BY (2012) Cellular and molecular biology of optineurin. Int Rev Cell Mol Biol 294: 223-258.
10. Schwamborn K, Weil R, Courtois G, Whiteside ST, Israel A (2000) Phorbol esters and cytokines regulate the expression of the NEMO-related protein, a molecule involved in a NF-kappa B-independent pathway. J Biol Chem 275: 22780-22789. (Pubitemid 30646161)
11. Li Y, Kang J, Horwitz MS (1998) Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains. Mol Cell Biol 18: 1601-1610. (Pubitemid 28100926)
12. Rezaie T, Sarfarazi M (2005) Molecular cloning, genomic structure, and protein characterization of mouse optineurin. Genomics 85: 131-138. (Pubitemid 39655697)
13. Stroissnigg H, Repitz M, Miloloza A, Linhartova I, Beug H, et al. (2002) FIP-2, an IkappaB-kinase-gamma-related protein, is associated with the Golgi apparatus and translocates to the marginal band during chicken erythroblast differentiation. Exp Cell Res 278: 133-145. (Pubitemid 35002098)
14. Ying H, Shen X, Park B, Yue BY (2010) Posttranslational modifications, localization, and protein interactions of optineurin, the product of a glaucoma gene. PLoS ONE 5: e9168.
15. Zhu G, Wu CJ, Zhao Y, Ashwell JD (2007) Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP. Curr Biol 17: 1438-1443. (Pubitemid 47259388)
16. Sudhakar C, Nagabhushana A, Jain N, Swarup G (2009) NF-kappaB mediates tumor necrosis factor alpha-induced expression of optineurin, a negative regulator of NF-kappaB. PLoS ONE 4: e5114.
17. Sahlender DA, Roberts RC, Arden SD, Spudich G, Taylor MJ, et al. (2005) Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis. J Cell Biol 169: 285-295. (Pubitemid 40656566)
18. Park BC, Shen X, Samaraweera M, Yue BY (2006) Studies of optineurin, a glaucoma gene: Golgi fragmentation and cell death from overexpression of wild-type and mutant optineurin in two ocular cell types. Am J Pathol 169: 1976-1989. (Pubitemid 351181959)
19. Nagabhushana A, Chalasani ML, Jain N, Radha V, Rangaraj N, et al. (2010) Regulation of endocytic trafficking of transferrin receptor by optineurin and its impairment by a glaucoma-associated mutant. BMC Cell Biol 11: 4.
20. Park B, Ying H, Shen X, Park JS, Qiu Y, et al. (2010) Impairment of protein trafficking upon overexpression and mutation of optineurin. PLoS ONE 5: e11547.
21. Anborgh PH, Godin C, Pampillo M, Dhami GK, Dale LB, et al. (2005) Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin. J Biol Chem 280: 34840-34848. (Pubitemid 41504618)
22. Mankouri J, Fragkoudis R, Richards KH, Wetherill LF, Harris M, et al. (2010) Optineurin negatively regulates the induction of IFNbeta in response to RNA virus infection. PLoS Pathog 6: e1000778.
23. Korac J, Schaeffer V, Kovacevic I, Clement AM, Jungblut B, et al. (2013) Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates. J Cell Sci 126: 580-592.
24. Park BC, Tibudan M, Samaraweera M, Shen X, Yue BY (2007) Interaction between two glaucoma genes, optineurin and myocilin. Genes Cells 12: 969-979. (Pubitemid 47261991)
25. Nagabhushana A, Bansal M, Swarup G (2011) Optineurin is required for CYLD-dependent inhibition of TNFalpha-induced NF-kappaB activation. PLoS ONE 6: e17477.
26. Hattula K, Peranen J (2000) FIP-2, a coiled-coil protein, links Huntingtin to Rab8 and modulates cellular morphogenesis. Curr Biol 10: 1603-1606. (Pubitemid 32062664)
27. del Toro D, Alberch J, Lazaro-Dieguez F, Martin-Ibanez R, Xifro X, et al. (2009) Mutant huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/Rab8 complex from the Golgi apparatus. Mol Biol Cell 20: 1478-1492.
28. Moreland RJ, Dresser ME, Rodgers JS, Roe BA, Conaway JW, et al. (2000) Identification of a transcription factor IIIA-interacting protein. Nucleic Acids Res 28: 1986-1993. (Pubitemid 30229666)
29. Chalasani ML, Radha V, Gupta V, Agarwal N, Balasubramanian D, et al. (2007) A glaucoma-associated mutant of optineurin selectively induces death of retinal ganglion cells which is inhibited by antioxidants. Invest Ophthalmol Vis Sci 48: 1607-1614. (Pubitemid 351261344)
30. Meng Q, Lv J, Ge H, Zhang L, Xue F, et al. (2012) Overexpressed mutant optineurin(E50K) induces retinal ganglion cells apoptosis via the mitochondrial pathway. Mol Biol Rep 39: 5867-5873.
31. Chi ZL, Akahori M, Obazawa M, Minami M, Noda T, et al. (2010) Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice. Hum Mol Genet 19: 2606-2615.
32. Minegishi Y, Iejima D, Kobayashi H, Chi ZL, Kawase K, et al. (2013) Enhanced optineurin E50K-TBK1 interaction evokes protein insolubility and initiates familial primary open-angle glaucoma. Hum Mol Genet 22: 3559-3567.
33. Tezel G, Wax MB (2000) Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci 20: 8693-8700.
34. Tezel G, Li LY, Patil RV, Wax MB (2001) TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 42: 1787-1794. (Pubitemid 32652354)
35. Yuan L, Neufeld AH (2000) Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 32: 42-50.
36. Tanito M, Kaidzu S, Takai Y, Ohira A (2012) Status of systemic oxidative stresses in patients with primary open-angle glaucoma and pseudoexfoliation syndrome. PLoS ONE 7: e49680.
37. Izzotti A, Sacca SC, Cartiglia C, De Flora S (2003) Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am J Med 114: 638-646. (Pubitemid 36703232)
38. Nucci C, Tartaglione R, Rombola L, Morrone LA, Fazzi E, et al. (2005) Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat. Neurotoxicology 26: 935-941. (Pubitemid 41427534)
39. De Marco N (2006) Optineurin Increases Cell Survival and Translocates to the Nucleus in a Rab8-dependent Manner upon an Apoptotic Stimulus. Journal of Biological Chemistry 281: 16147-16156.
40. De Marco N, Buono M, Troise F, Diez-Roux G (2006) Optineurin increases cell survival and translocates to the nucleus in a Rab8-dependent manner upon an apoptotic stimulus. J Biol Chem 281: 16147-16156. (Pubitemid 43848510)
41. Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S (2003) Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115: 565-576. (Pubitemid 37506045)
42. Agou F, Ye F, Goffinont S, Courtois G, Yamaoka S, et al. (2002) NEMO trimerizes through its coiled-coil C-terminal domain. J Biol Chem 277: 17464-17475. (Pubitemid 34967546)
43. Tegethoff S, Behlke J, Scheidereit C (2003) Tetrameric oligomerization of IkappaB kinase gamma (IKKgamma) is obligatory for IKK complex activity and NF-kappaB activation. Mol Cell Biol 23: 2029-2041. (Pubitemid 36278814)
44. Ivins FJ, Montgomery MG, Smith SJ, Morris-Davies AC, Taylor IA, et al. (2009) NEMO oligomerization and its ubiquitin-binding properties. Biochem J 421: 243-251.
45. Wang CX, Hosono K, Ohtsubo M, Gao J, Ohishi K, et al. (2013) Interaction between optineurin and the bZIP transcription factor NRL. Cell Biol Int. (in press)
46. Nooren IM, Thornton JM (2003) Structural characterisation and functional significance of transient protein-protein interactions. J Mol Biol 325: 991-1018. (Pubitemid 36263408)
47. Nooren IM, Thornton JM (2003) Diversity of protein-protein interactions. EMBO J 22: 3486-3492. (Pubitemid 36898326)
48. Wittig I, Beckhaus T, Wumaier Z, Karas M, Schagger H (2010) Mass estimation of native proteins by blue native electrophoresis: principles and practical hints. Mol Cell Proteomics 9: 2149-2161.
49. Schagger H, Cramer WA, von Jagow G (1994) Analysis of molecular masses and oligomeric states of protein complexes by blue native electrophoresis and isolation of membrane protein complexes by two-dimensional native electrophoresis. Anal Biochem 217: 220-230. (Pubitemid 24080754)
50. Agou F, Traincard F, Vinolo E, Courtois G, Yamaoka S, et al. (2004) The trimerization domain of NEMO is composed of the interacting C-terminal CC2 and LZ coiled-coil subdomains. J Biol Chem 279: 27861-27869. (Pubitemid 38900054)
51. Grant AJ, Jessup W, Dean RT (1992) Accelerated endocytosis and incomplete catabolism of radical-damaged protein. Biochim Biophys Acta 1134: 203-209.
52. Friguet B, Stadtman ER, Szweda LI (1994) Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease. J Biol Chem 269: 21639-21643.
53. Davies KJ (2001) Degradation of oxidized proteins by the 20S proteasome. Biochimie 83: 301-310.
54. Poppek D, Grune T (2006) Proteasomal defense of oxidative protein modifications. Antioxid Redox Signal 8: 173-184. (Pubitemid 43324544)
55. Souza JM, Giasson BI, Chen Q, Lee VM, Ischiropoulos H (2000) Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J Biol Chem 275: 18344-18349. (Pubitemid 30414790)
56. Krishnan S, Chi EY, Wood SJ, Kendrick BS, Li C, et al. (2003) Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis. Biochemistry 42: 829-837. (Pubitemid 36133308)
57. Hensley K, Hall N, Subramaniam R, Cole P, Harris M, et al. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem 65: 2146-2156.
58. Swaab DF, Lucassen PJ, Salehi A, Scherder EJ, van Someren EJ, et al. (1998) Reduced neuronal activity and reactivation in Alzheimer's disease. Prog Brain Res 117: 343-377. (Pubitemid 28530701)